Pictet Asset Management Holding Sa Regeneron Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 286,545 shares of REGN stock, worth $201 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
286,545
Previous 293,764
2.46%
Holding current value
$201 Million
Previous $309 Million
2.44%
% of portfolio
0.34%
Previous 0.36%
Shares
5 transactions
Others Institutions Holding REGN
# of Institutions
1,534Shares Held
83.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.54 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.93 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.26 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.44 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.02 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $75.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...